Siyi Liu

Changsha, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Construction and Validation of Frailty Risk Prediction Model for Community-Dwelling Elderly Individuals With Chronic Diseases.

Construction and Validation of Frailty Risk Prediction Model for Community-Dwelling Elderly Individuals With Chronic Diseases.

Journal: Journal of clinical nursing
Published: January 10, 2026

CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5-Mediated Glutamine Metabolism Through YY1.

CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5-Mediated Glutamine Metabolism Through YY1.

Journal: Cancer science
Published: November 20, 2025

CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis.

CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis.

Journal: Cancer cell international
Published: October 26, 2025

Chemotherapy-induced senescent nasopharyngeal carcinoma cells suppress NK cell-mediated antitumor immunity by upregulating EBI3 via mtDNA-cGAS-STING pathway.

Chemotherapy-induced senescent nasopharyngeal carcinoma cells suppress NK cell-mediated antitumor immunity by upregulating EBI3 via mtDNA-cGAS-STING pathway.

Journal: Cell communication and signaling : CCS
Published: September 18, 2025

RBFOX2: An RNA-binding protein with alternative splicing and non-alternative splicing regulatory functions.

RBFOX2: An RNA-binding protein with alternative splicing and non-alternative splicing regulatory functions.

Journal: Experimental and molecular pathology
Published: August 12, 2025

Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression.

Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression.

Journal: Signal transduction and targeted therapy
Published: May 09, 2025

CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein.

CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein.

Journal: International journal of biological macromolecules
Published: March 17, 2025

IGF2BP2: an m6A reader that affects cellular function and disease progression.

IGF2BP2: an m6A reader that affects cellular function and disease progression.

Journal: Cellular & molecular biology letters
Published: November 30, 2024

CD38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8+T cell-mediated anti-tumor immunity.

CD38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8+T cell-mediated anti-tumor immunity.

Journal: Nature communications
Published: October 14, 2024

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells.

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells.

Journal: Cancer drug resistance (Alhambra, Calif.)
Published: July 31, 2024

CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 axis.

CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 axis.

Journal: Heliyon
Published: July 15, 2024

CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression.

CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression.

Journal: Cell death discovery
Published: May 27, 2024
Showing 1-12 of 17

Last Updated: 09/26/2026